SA
ONC logo
BeOne Medicines AG(ONC)
Closing price · checked 4:12 PM ETAbout this dataData status
$390.94▼-8.76 (-2.19%)
After Hours:$390.94+0.00 (+0.00%)· 4:12 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

BeOne Medicines AG (ONC)

Total Current Liabilities

$2.23B

Quarterly · Period ending: · USD

ONC logo

ONC Total Current Liabilities

Latest reported$1.83B
ONC FY Current Liabilities ($31.73M → $1.83B)
High-resolution chart · PNG

What is total current liabilities?

Liabilities due within one year.

ONC total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

BeOne Medicines AG Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)Change
1,828,830,000−17.43%
2,214,899,000+22.36%
1,810,113,000+23.26%
1,468,528,000−8.19%
1,599,555,000+48.77%
1,075,199,000+246.49%
310,312,000+25.91%
246,452,000+64.31%
149,988,000+327.83%
35,058,000−0.32%
35,172,000+163.05%
13,371,000−57.87%
31,734,000—

Frequently asked questions: ONC total current liabilities

What is BeOne Medicines AG (ONC)'s current total current liabilities?

BeOne Medicines AG (ONC)'s latest reported total current liabilities (Quarterly) is $2.23B as of Sep 30, 2026. Liabilities due within one year.

How much historical total current liabilities data is available for ONC?

Stock Alarm Pro provides 13 dated annual fiscal periods observations for BeOne Medicines AG (ONC)'s total current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ONC's total current liabilities to peers or set an alert?

You can open ONC's total current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ONC delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.